• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Psychotic Disorders

Psychotic Disorders

Comprehensive Conceptualization and Treatments

9780190653279
1 368,90 zł
1 232,01 zł Zniżka 136,89 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 1 232,01 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Psychotic Disorders:: Comprehensive Conceptualization and Treatments emphasizes a dimensional approach to psychosis-one of the most fascinating manifestations of altered brain behavior-that cuts across a broad array of psychiatric diagnoses from schizophrenia to affective psychosis and organic disorders like epilepsy and dementias. Written by an international roster of over seventy leading experts in the field, this volume comprehensively reviews, critiques, and integratesavailable knowledge on the etiology, mechanisms, and treatments of psychotic disorders, and outlines ways forward in both research and clinical practice towards more objective, mechanistically-based definitions of psychotic disorders. Chapters address topics such as psychosis phenomenology, biomarkers andtreatments, the overlaps and interfaces between psychiatric disorders within the psychosis dimension, and novel disease definitions. Furthermore, the volume incorporates findings on potential mechanisms, bridges between various system levels (i.e., genetic, epigenetic, molecular and cellular, brain circuit and function, psychological, social, environmental and cultural) and their interactions, as well as the potential role in causation and/or mediation in psychotic disorders. Finally, thevolume outlines a broad array of treatment approaches, from the readily available (e.g., psychopharmacology, various modalities of psychotherapy) to the experimental (e.g., cognitive interventions, neuromodulation). With a concluding section of forward perspectives conjecturing future directions andrelated challenges, this book aspires to stimulate new knowledge, generate novel frameworks, and carry new directions forward on psychotic disorders.
Szczegóły produktu
OUP USA
98274
9780190653279
9780190653279

Opis

Rok wydania
2021
Numer wydania
1
Oprawa
twarda
Liczba stron
708
Wymiary (mm)
216 x 279
Waga (g)
2155
  • Section 1: Phenomenological characteristics and dimensional conceptualization of psychosis; 1. Conceptualization of psychosis in psychiatric nosology: past, present and the future; Matcheri S. Keshavan, John Torous, Rajiv Tandon; 2. Historical epistemology of the unitary psychosis; German E. Berrios, Ivana S. Markova; 3. Dimensional conceptualization of psychosis; Kürsat Altinbas, Sinan Guloksuz, and Jim van Os; Transdiagnostic dimensions of psychosis; 4. Applying Research Domain Criteria (RDoC) Dimensions to psychosis; Sarah E. Morris, Jennifer Pacheco, Charles A. Sanislow; 5. Schizophrenia, Schizoaffective disorder, Bipolar Disorder; Barrett Kern, Sarah K. Keedy; 6. Psychotic symptoms in bipolar disorder; Marsal Sanches, Xiang-Yang Zhang, and Jair C. Soares; 7. Major depressive disorder with psychotic features: confronting and resolving the dimensional challenge; John L. Waddington, Tara Kingston, Nnamdi Nkire, Vincent Russell; 8. Psychosis in Personality Disorders; Nidhi Kapil-Pair, Yulia Landa, Marie C. Hansen, Daniel H. Vaccaro, Marianne Goodman; 9. Symptom network models of psychosis; Adela-Maria Isvoranu, Lindy-Lou Boyette, Sinan Guloksuz, Denny Borsboom; Psychosis in general medical conditions and organic brain disorders; 10. Organic psychosis: phenotypic deviants or clues to schizophrenia?; Peter Buckley, Brian Miller; 11. Epilepsy and psychosis; Michael R. Trimble, Kousuke Kanemoto, Dale C. Hesdorffer; 12. Understanding sex differences in psychosis through the exploration of hormonal contributions; Leah H. Rubin; Section 2: Psychosis course and lifetime manifestations; Early Psychosis; 13. Clinical phenomenology of the prodrome for psychosis; Albert R. Powers III, Thomas H. McGlashan, Scott W. Woods; 14. Predictors of conversion to psychosis; Rachael G. Grazioplene, Tyrone D. Cannon; 15. First-episode psychosis: phenomenology, onset, course and early intervention (OPUS); Merete Nordentoft, Nikolai Albert; 16. Evidence based treatment and implementation for early psychosis; Sacha Zilkha, Iruma Bello, Hong Ngo, Samantha Jankowski, Lisa Dixon; Psychosis Over Life Span and Late-Life Psychosis; 17. Life span development of schizophrenia: symptoms, clinical course and outcomes; Matt Isohanni, Jouko Miettunen, Matti Penttilä; 18. Phenomenological characteristics of psychosis of aging: psychosis and dementia interphase; Graham M.L. Eglit, Barton W. Palmer, Dilip V. Jeste; Section 3: Neurobiology of psychosis; Heritability and Genetics; 19. Genetic neuropathology revisited: gene expression in psychosis; Samuel J. Allen; Rahul Bharadwaj,, Thomas M. Hyde, Joel E. Kleinman; 20. Epigenomic regulation in psychosis; Bibi S. Kassim, Behnam Javidfar, Schahram Akbarian; 21. DNA modifications in schizophrenia; Ehsan Pishva, Bart P. F. Rutten, Jonathan Mill; 22. Endophenotypes: a window on the genetics of schizophrenia; David Braff; Cognitive Biomarkers of psychosis; 23. Cognitive biomarkers of psychosis; S. Kristian Hill, Richard S.E. Keefe, John A. Sweeney; 24. Social cognition in psychosis; Amy E. Pinkham, David L. Roberts; 25. Self-awareness in schizophrenia: affected domains and their impact; Juliet M. Silberstein, Amy E. Pinkham, Philip D. Harvey; Neurophysiologic biomarkers of psychosis; 26. Neurophysiologic biomarkers of psychosis: Event-related potential biomarkers; Judith M. Ford, Holly K. Hamilton, Katiah Llerena, Brian J. Roach, Daniel H. Mathalon; 27. Oculomotor biomarkers of illness, risk, and pharmacogenetic treatment effects across the psychosis spectrum; James L Reilly, Jennifer McDowell, Jeffrey Bishop, Andreas Sprenger, Rebekka Lencer; Brain imaging biomarkers; 28. Structural connectivity in psychosis; Amanda E. Lyall, Johanna Seitz, Marek Kubicki; 29. Functional connectivity biomarkers of psychosis; Godfrey Pearlson, Michael Stevens; 30. MR Spectroscopy; Adrienne C. Lahti, Nina V. Kraguljac; Pathophysiology of Psychosis: Neurotransmitters; 31. Dopaminergic mechanisms underlying psychosis; Oliver Howes & Michael Bloomfield; 32. Glutamate in the pathophysiology of schizophrenia; Daniel C. Javitt; 33. GABAergic Mechanisms in Psychosis; Takanori Hashimoto, David A Lewis; 34. Alteration in nicotinic receptors in psychotic disorders: molecular neurobiology and clinical relevance; Robert Freedman; 35. Muscarinic acetylcholine receptors in the etiology and treatment of schizophrenia; M.S. Moehle, S. E. Yohn, and P. J. Conn; 36. Kynurenic acid in brain function and dysfunction: focus on the pathophysiology and treatment of schizophrenia; Robert Schwarcz and Sophie Erhardt; Pathophysiology: Voltage-gated ion channels in psychosis ; 37. Genetic Association of Voltage-gated Ion Channels with Psychotic Disorders; Charles H Large; 38. Voltage-gated Ion channels in neural circuits implicated in psychotic disorders; Charles H Large; Pathophysiology: Immune Mechanisms ; 39. Inflammatory mechanisms in psychosis; Anna P. McLaughlin, Carmine M. Pariante, Valeria Mondelli; 40. Autoimmune processes in mental disorders; Marina Mane-Damas, Carolin Hoffmann, Shenghua Zong, Peter C. Molenaar, Mario Losen, Pilar Martinez-Martinez; Brain circuit alterations in psychosis; 41. The circuitry of midbrain dopamine system dysregulation in schizophrenia; Felipe V. Gomes, Eric C. Zimmerman, Anthony A. Grace; 42. Feeling and remembering: effects of psychosis on the structure and function of the amygdala and hippocampus; M.D. Bauman, J.D. Ragland, C.M. Schumann; 43. The cerebellum in psychosis; Kelsey Heslin, Joe Shaffer, Albert Powers, Nancy Andreasen, and Krystal Parker; Section 4: Socio-environmental mechanistic factors in psychosis; Early life adversity; 44. Perinatal factors in psychosis; Mary Clarke, Mary Cannon; 45. The role of early life experience in psychosis; Richard P. Bentall; 46. Socio-environmental adversity across the life span; Peter Bosanac, David Castle; 47. Migration, ethnicity, and psychoses; Craig Morgan; Psychological mechanisms and psychosis; 48. Cognitive and emotional processes in psychosis; Steffen Moritz, Thies Lüdtke, Lukasz Gaweda, Jakob Scheunemann, and Ryan P. Balzan; 49. Aberrant salience attribution and psychosis; Toby T. Winton- Brown and Shitij Kapur; Neural correlates of socio-environmental risk and psychosis; 50. Neural correlates of childhood trauma; Alaptagin Khan, Kyoko Ohashi, Maria Maierd, Martin H. Teicher; 51. Neural correlates of urban risk environments; Imke L.J. Lemmers-Jansen, Anne-Kathrin J. Fett, Lydia Krabbendam; 52. Neural correlates of ethnic minority position and risk for psychosis; Jean-Paul Selten, Jan Booij, Bauke Buwalda, Andreas Meyer-Lindenberg; 53. Resilience in psychosis spectrum disorder; Lotta-Katrin Pries, Sinan Guloksuz, Bart P. F. Rutten; Section 5: Treatment of psychotic disorders; Pharmacological Treatments; 54. Pharmacological approaches to treatment; Stefan Leucht, Andrea Cipriani, Toshi A. Furukawa; 55. Animal models of psychosis: approaches and validity; Daniel Scott; Psychological treatments in psychosis; 56. Psychoanalytic treatment of psychosis; Elyn R. Saks; 57. Cognitive-behavioral therapy; Tania Lincoln, Alison Brabban; 58. Psychoeducation as an approach to treatment of severe mental illness; Emma Sophia Kay, David E. Pollio, Carol S. North; 59. Family Interventions in psychosis; Juliana Onwumere, Elizabeth Kuipers; 60. Peer support for people with psychiatric illness: A comprehensive review; Chyrell D. Bellamy, Anne S. Klee, Xavier Cornejo, Kimberly Guy, Mark Costa, Larry Davidson; 61. Mind-body approaches, mindfulness; Louise Johns, Mark Hayward, Clara Strauss, Eric Morris; 62. Hearing voices groups; Alison Branitsky, Eleanor Longden and Dirk Corstens; 63. AVATAR Therapy: a new digital therapy for Auditory Verbal Hallucinations; Tom K.J. Craig, Mar Rus-Calafell; 64. Health in a connected world; Philippe Delespaul and Catherine van Zelst; 65. Recovery-oriented services; Mike Slade, Eleanor Longden, Julie Repper, Samson Tse; Cognitive Remediation and Other Approaches; 66. Neuroscience-informed cognitive training for psychotic spectrum illnesses; Sophia Vinogradov, Rana Elmaghraby, Laura Pientka; 67. Cognitive remediation: theory, meta-analytic evidence, and practice; Til Wykes and Adam Crowther; 68. Noninvasive brain stimulation techniques in psychosis; Marine Mondino, Frederic Haesebaert, Jerome Brunelin; Early interventions; 69. Treatment approaches in the psychosis prodrome; Andrea M. Auther and Barbara A. Cornblatt; 70. From early intervention in psychosis to transformation of youth mental health reform; Ashok Malla, Patrick McGorry; Section 6: Future directions and opportunities; 71. Future directions: making a start towards the primary prevention of psychosis; Robin M Murray, Olesya Ajnakina and Marta Di Forti; 72. A glimpse forward regarding psychopathology of psychotic disorders; William T. Carpenter; 73. Time for change in psychosis research; Brett A. Clementz;
Komentarze (0)